Alpha-1 antitrypsin (AAT) deficiency is a common monogenic disorder in which there is a strong founder effect of a single missense mutation in SERPINA1, the gene encoding this major circulating serum anti-protease that is normally expressed primarily in hepatocytes. These features make AAT deficiency particularly attractive as a target for therapeutic gene editing using a wide variety of approaches.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/978-1-0716-3605-3_1 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!